Recent advances on visual cycle protein research and progress on clinical translation

Since the publication of our previous paper, Visual cycle proteins: Structure, function, and roles in human retinal disease (Tsin, et.al, JBC 293:13016, 2018) there has been significant progress on multiple topics discussed in this paper. In the present communication, we further explore research advances on two visual cycle proteins: DES1 and IRBP. In addition, we emphasize the progress of clinical translation of other visual cycle protein research, including the breakthrough of FDA-approved gene therapy for Leber’s congenital amaurosis, and additional gene therapies at different stages of clinical trials for various retinal diseases such as retinitis pigmentosa, diabetic retinopathy, and Stargardt’s disease.

[1]  B. Berkowitz.  Preventing diabetic retinopathy by mitigating subretinal space oxidative stress in vivo , 2020, Visual Neuroscience.

[2]  Ying Li,et al.  circRNA_0084043 contributes to the progression of diabetic retinopathy via sponging miR-140-3p and inducing TGFA gene expression in retinal pigment epithelial cells. , 2020, Gene.

[3]  I. Fernández-Bueno,et al.  Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases , 2020, Neural regeneration research.

[4]  B. Lujan,et al.  Retinal gene therapy in X-linked retinitis pigmentosa caused by mutations in RPGR: Results at 6 months in a first in human clinical trial , 2020, Nature Medicine.

[5]  J. Hurley,et al.  Non-photopic and photopic visual cycles differentially regulate immediate, early, and late phases of cone photoreceptor-mediated vision , 2020, The Journal of Biological Chemistry.

[6]  W. Hauswirth,et al.  Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  K. Palczewski,et al.  Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Yingbin Fu,et al.  Deletion of M-opsin prevents “M cone” degeneration in a mouse model of Leber congenital amaurosis , 2019, bioRxiv.

[9]  J. Bennett,et al.  Utility of In Vitro Mutagenesis of RPE65 Protein for Verification of Mutational Pathogenicity Before Gene Therapy. , 2019, JAMA ophthalmology.

[10]  Ian C. Han,et al.  Development of a Molecularly Stable Gene Therapy Vector for the Treatment of RPGR-associated X-linked Retinitis Pigmentosa. , 2019, Human gene therapy.

[11]  Jennifer K. Sun,et al.  Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy , 2019, Science Translational Medicine.

[12]  G. Fain,et al.  Light-Driven Regeneration of Cone Visual Pigments through a Mechanism Involving RGR Opsin in Müller Glial Cells , 2019, Neuron.

[13]  M. Gillies,et al.  Simvastatin protects photoreceptors from oxidative stress induced by all‐trans‐retinal, through the up‐regulation of interphotoreceptor retinoid binding protein , 2019, British journal of pharmacology.

[14]  C. Cepko,et al.  Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa , 2019, Proceedings of the National Academy of Sciences.

[15]  Karen M. Lins-Childers,et al.  Outer Retinal Oxidative Stress Measured In Vivo Using QUEnch-assiSTed (QUEST) OCT , 2019, Investigative ophthalmology & visual science.

[16]  S. Freeman,et al.  Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa , 2019, International Journal of Retina and Vitreous.

[17]  Haiyan Jiang,et al.  Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 , 2019, Nature Medicine.

[18]  K. Palczewski,et al.  Conditional deletion of Des1 in the mouse retina does not impair the visual cycle in cones , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Y. Le,et al.  Critical Role of Trophic Factors in Protecting Müller Glia: Implications to Neuroprotection in Age-Related Macular Degeneration, Diabetic Retinopathy, and Anti-VEGF Therapies. , 2019, Advances in experimental medicine and biology.

[20]  Mark E Pennesi,et al.  Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease , 2019, Pharmaceutical Research.

[21]  A. J. Roman,et al.  Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect , 2018, Nature Medicine.

[22]  Jeffery Grigsby,et al.  Visual cycle proteins: Structure, function, and roles in human retinal disease , 2018, The Journal of Biological Chemistry.

[23]  A. Ljubimov,et al.  Stem cell therapies in the treatment of diabetic retinopathy and keratopathy , 2016, Experimental biology and medicine.

[24]  R. Allikmets,et al.  Gene Therapy of ABCA4-Associated Diseases. , 2015, Cold Spring Harbor perspectives in medicine.

[25]  Shannon M. Conley,et al.  Gene therapy for Stargardt disease associated with ABCA4 gene. , 2014, Advances in experimental medicine and biology.

[26]  K. Palczewski,et al.  Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina , 2013, Proceedings of the National Academy of Sciences.

[27]  T. L. McGee,et al.  Low prevalence of LRAT mutations in patients with Leber congenital amaurosis and autosomal recessive retinitis pigmentosa , 2007, Molecular vision.

[28]  F. Gonzalez-fernandez,et al.  Interphotoreceptor retinoid-binding protein––an old gene for new eyes , 2003, Vision Research.